NNP
NVO

Nachman Norwood & Parrott’s Novo Nordisk NVO Stock Holding History

Nachman Norwood & Parrott’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-344
Closed -$12K – 776
2020
Q3 		$12K Buy
+344
New +$11.5K ﹤0.01% 719

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Nachman Norwood & Parrott's NVO Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Novo Nordisk (NVO) in Q4 2020, closing a stake of 344 shares — an estimated $12K sold.

Nachman Norwood & Parrott first reported a position in NVO in Q3 2020 and held it in 1 quarter. The position peaked at $12K in Q3 2020. 702 funds tracked by Wall St. Rank hold NVO as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining Novo Nordisk position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 344 Novo Nordisk shares in Q4 2020, an estimated $12K.
  • Nachman Norwood & Parrott first reported a position in Novo Nordisk in Q3 2020 and held it in 1 quarter.
  • Nachman Norwood & Parrott's Novo Nordisk position peaked at $12K in Q3 2020.
  • 702 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.